Administration of verapamil, a non-selective P-glycoprotein inhibitor, has been suggested by some researchers as a sensitizer to ASM in drug-resistant epilepsy and SE [220], but others argued against it due to possible inhibition of ASM [99]. This evidence concerns the gene ABCB1 and epilepsy.